Calamos Wealth Management »

Travere Therapeutics shares owned by Calamos Wealth Management

Quarter-by-quarter ownership of Travere Therapeutics shares owned by Calamos Wealth Management from 13F filings

Historical chart of Calamos Wealth Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Calamos Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Calamos Wealth Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $122k 103k 1.18

More positions owned by Calamos Wealth Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr S&p 500 Val Etf (IVE)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Ishares Tr Msci Acwi Ex Us (ACWX)
Ishares Tr Russell 3000 Etf (IWV)
Victory Portfolios Ii Core Bd Etf (UITB)
Broadcom (AVGO)
Applied Materials (AMAT)
Meta Platforms Cl A (META)
Calamos Etf Tr Autoc Incom Etf (CAIE)

View all positions for Calamos Wealth Management

Top funds holding Travere Therapeutics

Context Capital Management
Calamos Advisors
RWC Asset Management
Calamos Wealth Management
Rsm Us Wealth Management

View all funds holding Travere Therapeutics